Related Experiment Video
Updated: Jul 16, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
500
Current Weight Loss Medications: What Plastic Surgeons Should Know.
Aesthetic Surgery Journal
|September 14, 2023
Summary
Antidiabetic drugs are increasingly used for weight loss. Plastic surgeons must understand their benefits and risks for patients seeking aesthetic procedures and weight management.
Area of Science:
- Pharmacology and Endocrinology
- Plastic Surgery and Aesthetic Medicine
Background:
- Global obesity epidemic: Over 650 million adults are obese worldwide, according to the World Health Organization (WHO).
- Emerging trend: Antidiabetic medications are gaining popularity as effective weight loss treatments.
- Clinical relevance: Increased patient use necessitates understanding for plastic surgery practices and medical spas.
Purpose of the Study:
- To explore the potential benefits of antidiabetic medications for weight loss in plastic surgery patients.
- To outline critical safety considerations and synergistic effects when these medications are used.
- To provide guidance for incorporating these agents into aesthetic and weight management protocols.
Main Methods:
- Review of scientific literature on antidiabetic medications used for weight loss.
- Analysis of mechanisms of action, clinical efficacy, and adverse event profiles.
- Discussion of practical considerations for plastic surgeons and medical spa practitioners.
Main Results:
- Antidiabetic drugs demonstrate significant efficacy in promoting weight loss through various mechanisms.
- Potential side effects and contraindications require careful patient selection and monitoring.
- Synergistic effects with aesthetic procedures warrant further investigation and clinical awareness.
Conclusions:
- Antidiabetic medications offer a promising adjunct for weight management in plastic surgery candidates.
- A thorough understanding of pharmacology, efficacy, and safety is crucial for successful integration.
- Further research is needed to optimize their use in aesthetic medicine and patient outcomes.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
270
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
270
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
203
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
203
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
696
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
696
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
112
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
112
Drugs for Treatment of Constipation-Predominant IBS
201
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
201
Glucagon-like Receptor Agonists
357
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
357

